Free Trial

ValiRx (VAL) Competitors

ValiRx logo
GBX 0.72 -0.01 (-1.38%)
(As of 12/20/2024 11:48 AM ET)

VAL vs. EQT, CRC, WEB, NBL, FTO, TXO, NBR, COP, HAL, and WTI

Should you be buying ValiRx stock or one of its competitors? The main competitors of ValiRx include EQTEC (EQT), Circle Property (CRC), Webis (WEB), 18564 (NBL.L) (NBL), 2059984 (FTO.L) (FTO), 282082 (TXO.L) (TXO), 60884 (NBR.L) (NBR), Casino, Guichard-Perrachon Societe Anonyme (COP), HaloSource (HAL), and LS WTI Oil ETC (WTI). These companies are all part of the "petroleum and natural gas" industry.

ValiRx vs.

EQTEC (LON:EQT) and ValiRx (LON:VAL) are both small-cap industrials companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, community ranking, profitability, risk, analyst recommendations, dividends and media sentiment.

In the previous week, EQTEC's average media sentiment score of 0.00 equaled ValiRx'saverage media sentiment score.

Company Overall Sentiment
EQTEC Neutral
ValiRx Neutral

EQTEC has a beta of 2.07, meaning that its share price is 107% more volatile than the S&P 500. Comparatively, ValiRx has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500.

1.5% of EQTEC shares are held by institutional investors. 15.6% of EQTEC shares are held by company insiders. Comparatively, 18.3% of ValiRx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

ValiRx received 79 more outperform votes than EQTEC when rated by MarketBeat users. However, 66.98% of users gave EQTEC an outperform vote while only 51.55% of users gave ValiRx an outperform vote.

CompanyUnderperformOutperform
EQTECOutperform Votes
71
66.98%
Underperform Votes
35
33.02%
ValiRxOutperform Votes
150
51.55%
Underperform Votes
141
48.45%

ValiRx has lower revenue, but higher earnings than EQTEC. ValiRx is trading at a lower price-to-earnings ratio than EQTEC, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EQTEC£3.85M0.33-£24.55M-£0.17-2.86
ValiRxN/AN/A-£1.97M-£0.02-35.75

ValiRx's return on equity of -55.38% beat EQTEC's return on equity.

Company Net Margins Return on Equity Return on Assets
EQTECN/A -83.34% -14.55%
ValiRx N/A -55.38%-35.98%

Summary

EQTEC beats ValiRx on 6 of the 11 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VAL vs. The Competition

MetricValiRxBiotechnology IndustryMedical SectorLON Exchange
Market Cap£946,000.00£165.68M£5.14B£1.90B
Dividend Yield0.63%3.64%5.09%5.45%
P/E Ratio-35.75115.5190.131,861.10
Price / SalesN/A18,531.021,116.25392,379.48
Price / Cash62.5012.8743.1028.59
Price / Book0.248.594.782.80
Net Income-£1.97M-£20.67M£120.31M£155.77M
7 Day Performance-7.74%-1.05%-1.92%-2.02%
1 Month Performance-57.31%174.77%13.65%21.62%
1 Year Performance-88.37%134.18%28.34%29.68%

ValiRx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VAL
ValiRx
N/AGBX 0.72
-1.4%
N/A-88.3%£946,000.00N/A-35.755,450Gap Down
High Trading Volume
EQT
EQTEC
N/AGBX 0.58
+1.8%
N/A+1,523.3%£1.48M£3.85M-3.38740
CRC
Circle Property
N/AGBX 3.50
-12.5%
N/AN/A£1.02M£7.57M50.001,060Gap Down
High Trading Volume
WEB
Webis
N/AGBX 0.08
-33.3%
N/A-95.0%£315,000.00£49.70M14.1350Gap Down
High Trading Volume
NBL
18564 (NBL.L)
N/AN/AN/AN/A£0.00N/A0.002,330
FTO
2059984 (FTO.L)
N/AN/AN/AN/A£0.00N/A0.00147,000
TXO
282082 (TXO.L)
N/AN/AN/AN/A£0.00N/A0.00170
NBR
60884 (NBR.L)
N/AN/AN/AN/A£0.00N/A0.0012,000High Trading Volume
COP
Casino, Guichard-Perrachon Societe Anonyme
N/AN/AN/AN/A£0.00N/A0.009,500High Trading Volume
HAL
HaloSource
N/AN/AN/AN/A£0.00N/A0.0045,000Gap Down
WTI
LS WTI Oil ETC
N/AGBX 15.39
-0.5%
N/AN/A£0.00N/A0.00320News Coverage

Related Companies and Tools


This page (LON:VAL) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners